Announcement by Tianjin Tyan Pharmaceuticals Co., Ltd. on its subsidiary's pharmaceuticals passing the generic drug consistency evaluation.
Announcement by Tianjin Tyan Pharmaceuticals Co., Ltd. on its subsidiary's pharmaceuticals passing the generic drug consistency evaluation.
Announcement on Tianjin Tianyao Pharmaceuticals Co., Ltd.'s subsidiary adding new specifications for pharmaceutical products and passing the consistency evaluation of generic drugs.
Announcement of Tianjin Tianyao Pharmaceuticals Co., Ltd.'s revision of the Company's Articles of Association and completion of business registration changes.
Announcement from Tianjin Tianyao Pharmaceuticals regarding the receipt of approval notification for the listing application of chemical raw materials active pharmaceutical ingredient.
Announcement of Tianjin Tianyao Pharmaceuticals Co., Ltd. regarding the application for loans by pledging its own assets by its subsidiary and related transactions
Announcement of Tianjin Tianyao Pharmaceuticals Co., Ltd. regarding Provision for Asset Impairment
Announcement of Tianjin Pharmaceutical Co., Ltd. on preparation for impairment
Announcement of Tianjin Pharmaceutical Co., Ltd. on the subsidiary obtaining a drug registration certificate
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Tianjin Pharmaceutical Co., Ltd.
Legal Opinion of Tianjin Changshi Law Firm on the 2023 Annual General Meeting of Shareholders of Tianjin Pharmaceutical
Announcement of Tianjin Pharmaceutical Co., Ltd. on the subsidiary obtaining a drug registration certificate
Materials of the 2023 Annual General Meeting of Shareholders of Tianjin Pharmaceutical Co., Ltd.
Notice of Jinyao Pharmaceutical Co., Ltd. on convening the 2023 Annual General Meeting of Shareholders
Announcement of Tianjin Pharmaceutical Co., Ltd. on preparation for impairment
Report on the performance of the Audit Committee of the Board of Directors of Tianjin Pharmaceutical Co., Ltd. 2023
Special instructions for financial services such as deposits and loans involving transactions related to financial companies for the 2023 fiscal year of Tianjin Pharmaceutical Co., Ltd.
Special report by the board of directors of Tianjin Pharmaceutical Co., Ltd. on the independence of independent directors
Report on the performance of supervisory duties of accounting firms by the Audit Committee of the Board of Directors in 2023
2023 Internal Control Evaluation Report of Jinyao Pharmaceutical Co., Ltd.
No Data